UA85645U - Method for correction of local lymphocoagulation at pancreatitis - Google Patents
Method for correction of local lymphocoagulation at pancreatitisInfo
- Publication number
- UA85645U UA85645U UAU201307027U UAU201307027U UA85645U UA 85645 U UA85645 U UA 85645U UA U201307027 U UAU201307027 U UA U201307027U UA U201307027 U UAU201307027 U UA U201307027U UA 85645 U UA85645 U UA 85645U
- Authority
- UA
- Ukraine
- Prior art keywords
- lymphocoagulation
- pancreatitis
- correction
- local
- solution
- Prior art date
Links
- 206010033645 Pancreatitis Diseases 0.000 title abstract 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 239000003527 fibrinolytic agent Substances 0.000 abstract 1
- 230000003480 fibrinolytic effect Effects 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 229940053973 novocaine Drugs 0.000 abstract 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for correction of local lymphocoagulation at pancreatitis comprising the medication administering and fibrinolytic medication mixture (0.25% novocaine solution - 100 ml Heparin - 1 ml (OD 5000), solution of nicotinic acid, 1% calculated for 1 ml per patient's body weight) is administered directly into the parapancreatic fiber by sonographically-controlled percutaneous puncture to the Lesgaft Grunfeld triangle- area.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201307027U UA85645U (en) | 2013-06-04 | 2013-06-04 | Method for correction of local lymphocoagulation at pancreatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201307027U UA85645U (en) | 2013-06-04 | 2013-06-04 | Method for correction of local lymphocoagulation at pancreatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA85645U true UA85645U (en) | 2013-11-25 |
Family
ID=52285162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201307027U UA85645U (en) | 2013-06-04 | 2013-06-04 | Method for correction of local lymphocoagulation at pancreatitis |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA85645U (en) |
-
2013
- 2013-06-04 UA UAU201307027U patent/UA85645U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ627274A (en) | Anesthetic compounds and related methods of use | |
| EP4299093A3 (en) | Wearable automatic injection device for controlled administration of therapeutic agents | |
| MY188825A (en) | High-concentration monoclonal antibody formulations | |
| UA115139C2 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| MX2013011175A (en) | Novel glucagon analogues. | |
| MY192033A (en) | Method of dosing and use of soft anticholinergic esters | |
| NZ595046A (en) | Compositions and methods for extended therapy with aminopyridines | |
| EA032951B1 (en) | Glutarimide derivative, use thereof, pharmaceutical composition based thereon, process for preparing same | |
| NZ606977A (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition | |
| PH12012502454A1 (en) | Formulations including amiodarone and salts thereof and methods of their manufacture and use | |
| WO2013155528A3 (en) | Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels | |
| MD20140004A2 (en) | Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia | |
| MX2015013155A (en) | Tetrandrine family pharmaceutical formulations and method. | |
| MX2019006942A (en) | Non-peptide oxytocin receptor agonists. | |
| UA85645U (en) | Method for correction of local lymphocoagulation at pancreatitis | |
| MX2014014816A (en) | Pharmaceutical composition for treating inflammation and pain. | |
| EA032959B1 (en) | APPLICATION OF BREEMELANOTIDE IN TREATMENT OF FEMALE SEXUAL DYSFUNCTION | |
| JO3689B1 (en) | Njectable formulations of paracetamol | |
| UA111785C2 (en) | A COMPOSITION FOR THE TREATMENT OF Warts And A WAY OF TREATMENT | |
| RU2011143250A (en) | METHOD OF ANESTHESIA IN SURGICAL TREATMENT OF COSOGLASION IN CHILDREN | |
| WO2013129977A3 (en) | Pharmaceutical composition for injections having neuroprotector, antiamnaesic, antioxidant, antihypoxic and antiischaemic activity (embodiments) | |
| MY169251A (en) | Injectable supersaturated acetaminophen solution for spinal administration | |
| RU2010131158A (en) | METHOD FOR PREVENTION OF RADIATING INJURIES TO DEHEATING WAYS | |
| UA75101U (en) | method for elimination of metabolic disorders in animals using anthelmintics Klozaverm-A | |
| UA82641U (en) | Method for treating neurosyphilis with parenchymatous alterations |